Skip to Main Content

Paper Details

Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers.
medRxiv
9
2021
COVID-19, N, NPA, PPA, RBD, SARS-CoV, SARS-CoV-2, SARS-CoV-2 IgG, SARS-CoV-2 antibodies, nucleocapsid, saliva, spike (S) antigens
Author NameAffiliation
Oliver LaeyendeckerJohns Hopkins University School of Medicine
Oliver LaeyendeckerNational Institute of Allergy and Infectious Diseases, National Institutes of Health
Shmuel ShohamJohns Hopkins University School of Medicine
Kelly A GeboBloomberg School of Public Health, Johns Hopkins University
Kelly A GeboJohns Hopkins University School of Medicine
Arturo CasadevallBloomberg School of Public Health, Johns Hopkins University
Arturo CasadevallBloomberg School of Public Health, Johns Hopkins University
Andrew PekoszBloomberg School of Public Health, Johns Hopkins University
Andrew PekoszBloomberg School of Public Health, Johns Hopkins University
Evan M BlochJohns Hopkins University School of Medicine
Aaron A R TobianJohns Hopkins University School of Medicine
Aaron A R TobianJohns Hopkins University School of Medicine
  • 1 - 12

Datasets

Release 1.2